Literature DB >> 5588903

On the occurrence of homovanillic acid and 5-hydroxyindol-3-ylacetic acid in the ventricular C.S.F. of patients suffering from parkinsonism.

H C Guldberg, J W Turner, A Hanieh, G W Ashcroft, T B Crawford, W L Perry, F J Gillingham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 5588903     DOI： 10.1159/000103680

Source DB:  PubMed          Journal:  Confin Neurol        ISSN： 0010-5678


× No keyword cloud information.
  10 in total

1.  Correlation of clinical symptoms, HVA and 5-HIAA in csf and plasma L-DOPA in Parkinsonian patients treated with L-DOPA and L-DOPA + RO 4-4602.

Authors:  G Campanella; S Algeri; C Cerletti; E Dolfini; A Jori; F Rinaldi
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

2.  Approaches to the study of cerebral dopamine metabolism in certain extrapyramidal diseases.

Authors:  V P Barkhatova; E I Kandel'; E G Demina
Journal:  Neurosci Behav Physiol       Date:  1985 Mar-Apr

3.  On the relationship between L-DOPA therapy and CSF monoamine metabolites in Parkinson's disease.

Authors:  C Casati; A Agnoli; A Jori; E Dolfini
Journal:  Z Neurol       Date:  1973-04-02

4.  Cerebrospinal fluid choline in extrapyramidal disorders.

Authors:  S M Aquilonius; B Nyström; J Schuberth; A Sundwall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-10       Impact factor: 10.154

5.  Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's disease.

Authors:  J J Mann; M Stanley; R D Kaplan; J Sweeney; A Neophytides
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-10       Impact factor: 10.154

6.  Phenolic acid concentrations in the lumbar cerebrospinal fluid of Parkinsonian patients treated with L-dopa.

Authors:  I A Pullar; J M Weddell; R Ahmed; F J Gillingham
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-12       Impact factor: 10.154

7.  Kantamaneni BD, Curzon G:Comparison of benefit from L-dopa in Parkinsonism with increase of amine metabolites in the CSF.

Authors:  R B Godwin-Austen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-06       Impact factor: 10.154

8.  Use of cerebrospinal fluid drawn at pneumoencephalography in the study of monoamine metabolism in man.

Authors:  E Garelis; T L Sourkes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-06       Impact factor: 10.154

Review 9.  Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.

Authors:  Félix J Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez
Journal:  Front Cell Neurosci       Date:  2014-11-11       Impact factor: 5.505

10.  Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study.

Authors:  Satoru Morimoto; Masaki Takao; Hiroyuki Hatsuta; Yasushi Nishina; Tadashi Komiya; Renpei Sengoku; Yuta Nakano; Akiko Uchino; Hiroyuki Sumikura; Yuko Saito; Kazutomi Kanemaru; Shigeo Murayama
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.